Cite

HARVARD Citation

    Gintant, G. et al. (2020). The roles of human induced pluripotent stem cell-derived cardiomyocytes in drug discovery: managing in vitro safety study expectations. Expert opinion on drug discovery. pp. 719-729. [Online]. 
  
Back to record